• / Free eNewsletters & Magazine
  • / My Account

High Risk

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. United States $609.88 Million Cytomegalovirus (CMV) Infection Market Insights, Epidemiology and Market Forecast, 2023 - Research and Markets

    United States $609.88 Million Cytomegalovirus (CMV) Infection Market Insights, Epidemiology and Market Forecast, 2023 - Research and Markets

  2. Global MEMS Microphone Market to Grow at a CAGR of 8.21%, 2017-2021 with Knowles Corporation, Goertek, AAC Technologies, InvenSense & STMicroelectronics Dominating - Research and Markets

    Global MEMS Microphone Market to Grow at a CAGR of 8.21%, 2017-2021 with Knowles Corporation, Goertek, AAC Technologies, InvenSense & STMicroelectronics Dominating - Research and Markets

  3. Comprehensive Health Services Joins International Stability Operations Association

    Comprehensive Health Services Joins International Stability Operations Association

  4. UPDATE: Could index investing become too risky?

    UPDATE: Could index investing become too risky?

  5. Cytomegalovirus (CMV) Infection - Epidemiology Insights - 2017-2023 - Research and Markets

    Cytomegalovirus (CMV) Infection - Epidemiology Insights - 2017-2023 - Research and Markets

  6. NGA Releases Biggest Collection of Arctic Elevation Data Yet at Esri FedGIS Conference

    NGA Releases Biggest Collection of Arctic Elevation Data Yet at Esri FedGIS Conference

  7. Project Management Institute and Members of Government Efficiency Caucus Discuss New Law Aimed at Improving Federal Government Efficiency

    Project Management Institute and Members of Government Efficiency Caucus Discuss New Law Aimed at Improving Federal Government Efficiency

  8. FINRA Hearing Panel Expels Red River Securities, LLC and Bars CEO Brian Keith Hardwick for Fraud; Ordered to Pay $24.6 Million in Restitution to Investors

    FINRA Hearing Panel Expels Red River Securities, LLC and Bars CEO Brian Keith Hardwick for Fraud; Ordered to Pay $24.6 Million in Restitution to Investors

  9. Aeterna Zentaris Announces Plans to Pursue FDA Registration of Macrilen™

    Aeterna Zentaris Announces Plans to Pursue FDA Registration of Macrilen™

  10. Butterfield Reports Full Year 2016 and Q4 2016 Results

    Butterfield Reports Full Year 2016 and Q4 2016 Results

12345

©2017 Morningstar Advisor. All right reserved.